Daurès JP - Search Results

1

Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer.

Pujol JL, Grenier J, Daurès JP, Daver A, Pujol H, Michel FB. Pujol JL, et al. Among authors: daures jp. Cancer Res. 1993 Jan 1;53(1):61-6. Cancer Res. 1993. PMID: 7677981

2

Neural cell adhesion molecule and prognosis of surgically resected lung cancer.

Pujol JL, Simony J, Demoly P, Charpentier R, Laurent JC, Daurès JP, Lehmann M, Guyot V, Godard P, Michel FB. Pujol JL, et al. Among authors: daures jp. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):1071-5. doi: 10.1164/ajrccm/148.4_Pt_1.1071. Am Rev Respir Dis. 1993. PMID: 8214927

3

A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol.

Pujol P, Maudelonde T, Daures JP, Rouanet P, Brouillet JP, Pujol H, Rochefort H. Pujol P, et al. Among authors: daures jp. Cancer. 1993 Mar 15;71(6):2006-12. doi: 10.1002/1097-0142(19930315)71:6<2006::aid-cncr2820710614>3.0.co;2-q. Cancer. 1993. PMID: 8443752

4

Lung cancer chemotherapy. Response-survival relationship depends on the method of chest tumor response evaluation.

Pujol JL, Parrat E, Lehmann M, Gautier V, Daurès JP, Michel FB, Godard P. Pujol JL, et al. Among authors: daures jp. Am J Respir Crit Care Med. 1996 Jan;153(1):243-9. doi: 10.1164/ajrccm.153.1.8542123. Am J Respir Crit Care Med. 1996. PMID: 8542123 Clinical Trial.

5

Cyfra 21-1, a new marker of lung cancer.

Grenier J, Pujol JL, Guilleux F, Daures JP, Pujol H, Michel FB. Grenier J, et al. Among authors: daures jp. Nucl Med Biol. 1994 Apr;21(3):471-6. doi: 10.1016/0969-8051(94)90070-1. Nucl Med Biol. 1994. PMID: 9296767 Clinical Trial.

6

Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis.

Boher JM, Pujol JL, Grenier J, Daurès JP. Boher JM, et al. Among authors: daures jp. Br J Cancer. 1999 Mar;79(9-10):1419-27. doi: 10.1038/sj.bjc.6690227. Br J Cancer. 1999. PMID: 10188885 Free PMC article.

7

Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data.

Choma D, Daurès JP, Quantin X, Pujol JL. Choma D, et al. Among authors: daures jp. Br J Cancer. 2001 Jul 6;85(1):14-22. doi: 10.1054/bjoc.2001.1892. Br J Cancer. 2001. PMID: 11437396 Free PMC article.

8

Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials.

Pujol JL, Barlesi F, Daurès JP. Pujol JL, et al. Among authors: daures jp. Lung Cancer. 2006 Mar;51(3):335-45. doi: 10.1016/j.lungcan.2005.11.001. Epub 2006 Feb 14. Lung Cancer. 2006. PMID: 16478643

9

Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.

Jacot W, Lhermitte L, Dossat N, Pujol JL, Molinari N, Daurès JP, Maudelonde T, Mangé A, Solassol J. Jacot W, et al. Among authors: daures jp. J Thorac Oncol. 2008 Aug;3(8):840-50. doi: 10.1097/JTO.0b013e31817e464a. J Thorac Oncol. 2008. PMID: 18670301 Free article.

10

Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.

Chakra M, Pujol JL, Lamy PJ, Bozonnat MC, Quantin X, Jacot W, Daurès JP. Chakra M, et al. Among authors: daures jp. J Thorac Oncol. 2008 Oct;3(10):1119-26. doi: 10.1097/JTO.0b013e318187464e. J Thorac Oncol. 2008. PMID: 18827607 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters